Bi-specific T Cell Engagers (BiTEs) are a type of immunotherapy designed to direct the body's immune system to target and eliminate cancer cells. These molecules are engineered to bind simultaneously to a T cell and a cancer cell, thereby bringing them into close proximity. This facilitates the activation of the T cell, leading to the destruction of the cancer cell.
